FORMULA FORIFIED W/ DOCOSAHEXAENOIC ACID (DHA) IN INFANTS W/ CYSTIC FIBROSIS

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。本研究的假设是，通过新生儿筛查，给诊断为CF的婴儿喂食添加了长链多不饱和脂肪酸的配方奶粉，将在生命的第一年改善生长（以年龄z分数的身高和体重来衡量）并减少胰腺功能障碍（以粪便中人类粪便弹性酶-1来衡量）。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The hypothesis of this study is that feeding infants diagnosed with CF via newborn screening a formula enhanced with long chain polyunsaturated fatty acid will improve growth (as measured by height and weight for age z-scores) and decrease pancreatic dysfunction (as measured by human fecal elastase-1 in stool) over the first year of life.